NTU Developmental Biology and Regenerative Medicine

國立臺灣大學發育生物學與再生醫學研究中心

Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

  • 2018, Journal and Article​
Read More